CART-ddBCMA
arcellx
['mmsm', 'car t']
exciting results from of ddbcma car t for r/r myeloma, with 69% of those with 12/12 followup maintaining a cr for a year or more - will be cool to see longer followup #mmsm #tcellrx #asco22 
haematology registrar | evidence-based medicine | MPH @Harvard | health policy @PORTAL_research | physiology | musician | writer | @_futurethinkers cofounder